Soundable Health is proud to announce that NAVER D2SF, the corporate venture capital arm of South Korea's leading technology company NAVER, has made a follow-on investment in Soundable Health's Pre-Series A round, citing the company's demonstrated product-market fit and strong growth trajectory in the U.S. healthcare market. This renewed commitment deepens a relationship that began at the very start: NAVER D2SF first backed Soundable Health in its seed round in 2019, and today's follow-on is a powerful validation of the progress made since.
Soundable Health's flagship product, proudP, an FDA-Class II device, has now been adopted by over 130 urology clinics across the United States.
Naver D2SF backs Soundable Health, Nuvilab to scale in North America →
